For the year ending 2025-12-31, SLNO has $563,830K in assets. $113,715K in debts. $70,106K in cash and cash equivalents.
| Balance Sheets | 2025-12-31 | |||
|---|---|---|---|---|
| Cash and cash equivalents | 70,106 | |||
| Marketable securities | 235,366 | |||
| Accounts receivable, net | 28,208 | |||
| Inventory, net | 15,024 | |||
| Prepaid expenses and other current assets | 7,110 | |||
| Total current assets | 355,814 | |||
| Property and equipment, gross | 308 | |||
| Less accumulated depreciation and amortization | 123 | |||
| Property and equipment, net | 185 | |||
| Operating lease right-of-use assets | 2,191 | |||
| Intangible assets, net | 4,861 | |||
| Long-term marketable securities | 200,616 | |||
| Other long-term assets | 163 | |||
| Total assets | 563,830 | |||
| Accounts payable | 12,435 | |||
| Accrued compensation | 9,677 | |||
| Operating lease liabilities | 726 | |||
| Contingent liability for essentialis purchase price | 20,327 | |||
| Other current liabilities | 18,198 | |||
| Total current liabilities | 61,363 | |||
| Long-term debt, net | 49,863 | |||
| Long-term lease liabilities | 1,964 | |||
| Other long-term liabilities | 525 | |||
| Total liabilities | 113,715 | |||
| Common stock, 0.001 par value, 100,000,000 shares authorized, 52,286,881 and 45,703,811 shares issued and outstanding at december 31, 2025 and 2024, respectively | 52 | |||
| Additional paid-in-capital | 881,018 | |||
| Accumulated other comprehensive income | 415 | |||
| Accumulated deficit | -431,370 | |||
| Total stockholders' equity | 450,115 | |||
| Total liabilities and stockholders'equity | 563,830 | |||
SOLENO THERAPEUTICS INC (SLNO)
SOLENO THERAPEUTICS INC (SLNO)